1,196 reports of this reaction
2.8% of all METHYLPREDNISOLONE ACETATE reports
#4 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #4 most commonly reported adverse reaction for METHYLPREDNISOLONE ACETATE, manufactured by Pharmacia & Upjohn Company LLC. There are 1,196 FDA adverse event reports linking METHYLPREDNISOLONE ACETATE to RHEUMATOID ARTHRITIS. This represents approximately 2.8% of all 42,188 adverse event reports for this drug.
Patients taking METHYLPREDNISOLONE ACETATE who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is a less commonly reported adverse event for METHYLPREDNISOLONE ACETATE, but still significant enough to appear in the safety profile.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for METHYLPREDNISOLONE ACETATE:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 1,196 FDA reports for METHYLPREDNISOLONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 2.8% of all adverse event reports for METHYLPREDNISOLONE ACETATE, making it a notable side effect.
If you experience rheumatoid arthritis while taking METHYLPREDNISOLONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.